<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Granules India Limited — News on 6ix</title>
<link>https://6ix.com/company/granules-india-limited</link>
<description>Latest news and press releases for Granules India Limited on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Sat, 04 Apr 2026 19:19:01 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/granules-india-limited" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo68364af078dffbe2df1531c0.webp</url>
<title>Granules India Limited</title>
<link>https://6ix.com/company/granules-india-limited</link>
</image>
<item>
<title>Press Release Apr 04 2026</title>
<link>https://6ix.com/company/granules-india-limited/news/press-release-apr-04-2026-1</link>
<guid isPermaLink="true">https://6ix.com/company/granules-india-limited/news/press-release-apr-04-2026-1</guid>
<pubDate>Sat, 04 Apr 2026 19:19:01 GMT</pubDate>
<description>Granules India Limited has informed the Exchange regarding a press release dated April 04, 2026, titled "Granules India Limited completes cGMP Audit at its Chantilly Site".</description>
</item>
<item>
<title>Press Release Mar 31 2026</title>
<link>https://6ix.com/company/granules-india-limited/news/press-release-mar-31-2026-13</link>
<guid isPermaLink="true">https://6ix.com/company/granules-india-limited/news/press-release-mar-31-2026-13</guid>
<pubDate>Tue, 31 Mar 2026 15:39:02 GMT</pubDate>
<description>Granules India Limited has informed the Exchange regarding a press release dated March 31, 2026, titled "Granules Life Sciences Receives VAI Classification following US FDA Inspection".</description>
</item>
<item>
<title>Press Release Mar 05 2026</title>
<link>https://6ix.com/company/granules-india-limited/news/press-release-mar-05-2026-8</link>
<guid isPermaLink="true">https://6ix.com/company/granules-india-limited/news/press-release-mar-05-2026-8</guid>
<pubDate>Thu, 05 Mar 2026 16:41:40 GMT</pubDate>
<description>Granules India Limited has informed the Exchange regarding a press release dated March 05, 2026, titled "Granules India s Packaging Facility in US gets FDA EIR with No Action Indicated Status".</description>
</item>
<item>
<title>Press Release Jan 23 2026</title>
<link>https://6ix.com/company/granules-india-limited/news/press-release-jan-23-2026-16</link>
<guid isPermaLink="true">https://6ix.com/company/granules-india-limited/news/press-release-jan-23-2026-16</guid>
<pubDate>Fri, 23 Jan 2026 22:09:46 GMT</pubDate>
<description>Granules India Limited has informed the Exchange regarding a press release dated January 23, 2026, titled "Press Release".</description>
</item>
<item>
<title>Press Release Jan 08 2026</title>
<link>https://6ix.com/company/granules-india-limited/news/press-release-jan-08-2026-13</link>
<guid isPermaLink="true">https://6ix.com/company/granules-india-limited/news/press-release-jan-08-2026-13</guid>
<pubDate>Thu, 08 Jan 2026 13:30:54 GMT</pubDate>
<description>Granules India Limited has informed the Exchange regarding a press release dated January 08, 2026, titled "CIN: L24110TG1991PLC012471 / Granules India Limited: 15th Floor, Granules Tower, Botanical Garden Road, Kondapur, Hyderabad 500084, Telangana, India.Press ReleaseGranules Pharmaceuticals, Inc. Receives FDA Tentative Approval with 180-Day Exclusivity for Generic Amphetamine Extended-Release Tablets (gDYANAVEL XR)".</description>
</item>
<item>
<title>Press Release Dec 22 2025</title>
<link>https://6ix.com/company/granules-india-limited/news/press-release-dec-22-2025-7</link>
<guid isPermaLink="true">https://6ix.com/company/granules-india-limited/news/press-release-dec-22-2025-7</guid>
<pubDate>Mon, 22 Dec 2025 12:47:25 GMT</pubDate>
<description>Granules India Limited has informed the Exchange regarding a press release dated December 22, 2025, titled "Granules Pharmaceuticals Inc. Receives FDA Tentative Approval for Generic Amphetamine Extended-Release Orally Disintegrating Tablets (ADZENYS XR-ODT®)".</description>
</item>
<item>
<title>Press Release Dec 04 2025</title>
<link>https://6ix.com/company/granules-india-limited/news/press-release-dec-04-2025-6</link>
<guid isPermaLink="true">https://6ix.com/company/granules-india-limited/news/press-release-dec-04-2025-6</guid>
<pubDate>Thu, 04 Dec 2025 17:15:24 GMT</pubDate>
<description>Granules India Limited has informed the Exchange regarding a press release dated December 04, 2025, titled "Press Release".</description>
</item>
<item>
<title>Press Release Dec 01 2025</title>
<link>https://6ix.com/company/granules-india-limited/news/press-release-dec-01-2025-14</link>
<guid isPermaLink="true">https://6ix.com/company/granules-india-limited/news/press-release-dec-01-2025-14</guid>
<pubDate>Mon, 01 Dec 2025 17:22:05 GMT</pubDate>
<description>Granules India Limited has informed the Exchange regarding a press release dated December 01, 2025, titled "Press Release".</description>
</item>
<item>
<title>Press Release Nov 13 2025</title>
<link>https://6ix.com/company/granules-india-limited/news/press-release-nov-13-2025-17</link>
<guid isPermaLink="true">https://6ix.com/company/granules-india-limited/news/press-release-nov-13-2025-17</guid>
<pubDate>Thu, 13 Nov 2025 18:59:29 GMT</pubDate>
<description>Granules India Limited has informed the Exchange regarding a press release dated November 13, 2025, titled "Press Release".</description>
</item>
<item>
<title>Press Release Nov 11 2025</title>
<link>https://6ix.com/company/granules-india-limited/news/press-release-nov-11-2025-16</link>
<guid isPermaLink="true">https://6ix.com/company/granules-india-limited/news/press-release-nov-11-2025-16</guid>
<pubDate>Tue, 11 Nov 2025 16:18:47 GMT</pubDate>
<description>Granules India Limited has informed the Exchange regarding a press release dated November 11, 2025, titled "Press Release".</description>
</item>
<item>
<title>Press Release Oct 29 2025</title>
<link>https://6ix.com/company/granules-india-limited/news/press-release-oct-29-2025-22</link>
<guid isPermaLink="true">https://6ix.com/company/granules-india-limited/news/press-release-oct-29-2025-22</guid>
<pubDate>Wed, 29 Oct 2025 16:45:33 GMT</pubDate>
<description>Granules India Limited has informed the Exchange regarding a press release dated October 29, 2025, titled "Press Release".</description>
</item>
<item>
<title>Press Release Aug 12 2025</title>
<link>https://6ix.com/company/granules-india-limited/news/press-release-aug-12-2025-18</link>
<guid isPermaLink="true">https://6ix.com/company/granules-india-limited/news/press-release-aug-12-2025-18</guid>
<pubDate>Tue, 12 Aug 2025 17:06:09 GMT</pubDate>
<description>Granules India Limited has informed the Exchange regarding a press release dated August 12, 2025, titled "Press Release".</description>
</item>
<item>
<title>Press Release May 28 2025</title>
<link>https://6ix.com/company/granules-india-limited/news/press-release-may-28-2025-14</link>
<guid isPermaLink="true">https://6ix.com/company/granules-india-limited/news/press-release-may-28-2025-14</guid>
<pubDate>Wed, 28 May 2025 17:50:54 GMT</pubDate>
<description>Granules India Limited has informed the Exchange regarding a press release dated May 28, 2025, titled "Press Release".</description>
</item>
<item>
<title>Press Release May 07 2025</title>
<link>https://6ix.com/company/granules-india-limited/news/press-release-may-07-2025-12</link>
<guid isPermaLink="true">https://6ix.com/company/granules-india-limited/news/press-release-may-07-2025-12</guid>
<pubDate>Wed, 07 May 2025 15:22:30 GMT</pubDate>
<description>Granules India Limited has informed the Exchange regarding a press release dated May 07, 2025, titled "Granules India Earns Gold Rating in First-Ever Corporate-Level EcoVadis AssessmentRanks in the Top 5% Globally Across All Industries".</description>
</item>
<item>
<title>Press Release Apr 10 2025</title>
<link>https://6ix.com/company/granules-india-limited/news/press-release-apr-10-2025-7</link>
<guid isPermaLink="true">https://6ix.com/company/granules-india-limited/news/press-release-apr-10-2025-7</guid>
<pubDate>Thu, 10 Apr 2025 20:29:52 GMT</pubDate>
<description>Granules India Limited has informed the Exchange regarding a press release dated April 10, 2025, titled "Granules India Announces Closing of Acquisition of Senn Chemicals, Strengthening Capabilities in Peptide Therapeutics and CDMO Services".</description>
</item>
<item>
<title>Press Release Feb 21 2025</title>
<link>https://6ix.com/company/granules-india-limited/news/press-release-feb-21-2025-3</link>
<guid isPermaLink="true">https://6ix.com/company/granules-india-limited/news/press-release-feb-21-2025-3</guid>
<pubDate>Sat, 22 Feb 2025 00:52:12 GMT</pubDate>
<description>Granules India Limited has informed the Exchange regarding a press release dated February 21, 2025, titled "Granules India enters the high growing peptide segment and CDMO business by acquiring Senn Chemicals AG. ".</description>
</item>
<item>
<title>Press Release Jan 30 2025</title>
<link>https://6ix.com/company/granules-india-limited/news/press-release-jan-30-2025-22</link>
<guid isPermaLink="true">https://6ix.com/company/granules-india-limited/news/press-release-jan-30-2025-22</guid>
<pubDate>Thu, 30 Jan 2025 18:13:50 GMT</pubDate>
<description>Granules India Limited has informed the Exchange regarding a press release dated January 30, 2025, titled "Granules Strengthens ADHD Portfolio with FDA Approval for Lisdexamfetamine Dimesylate Capsules".</description>
</item>
<item>
<title>Press Release Jan 24 2025</title>
<link>https://6ix.com/company/granules-india-limited/news/press-release-jan-24-2025-20</link>
<guid isPermaLink="true">https://6ix.com/company/granules-india-limited/news/press-release-jan-24-2025-20</guid>
<pubDate>Fri, 24 Jan 2025 18:16:19 GMT</pubDate>
<description>Granules India Limited has informed the Exchange regarding a press release dated January 24, 2025, titled "Press Release".</description>
</item>
<item>
<title>Press Release Dec 17 2024</title>
<link>https://6ix.com/company/granules-india-limited/news/press-release-dec-17-2024-5</link>
<guid isPermaLink="true">https://6ix.com/company/granules-india-limited/news/press-release-dec-17-2024-5</guid>
<pubDate>Tue, 17 Dec 2024 16:06:06 GMT</pubDate>
<description>Granules India Limited has informed the Exchange regarding a press release dated December 17, 2024, titled "Granules India Limited Announces FDA Approval for ADHD Treatment, Addressing Drug Shortages in the U.S.".</description>
</item>
<item>
<title>Press Release Nov 27 2024</title>
<link>https://6ix.com/company/granules-india-limited/news/press-release-nov-27-2024-9</link>
<guid isPermaLink="true">https://6ix.com/company/granules-india-limited/news/press-release-nov-27-2024-9</guid>
<pubDate>Wed, 27 Nov 2024 16:45:32 GMT</pubDate>
<description>Granules India Limited has informed the Exchange regarding a press release dated November 27, 2024, titled "Granules Net Zero Commitment Validated and Approved by Science Based Targets Initiative".</description>
</item>
</channel>
</rss>